N@N

DSM N.V.: DSM announces redesign of remuneration policy for the Managing Board

^{Published on 2009-03-09 14:17:43, Last Modified on 2009-03-09 14:18:40 - Market Wire}
 

HEERLEN, NETHERLANDS--(Marketwire - March 9, 2009) -

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that its Managing Board and Supervisory Board have decided to withdraw a proposal to the Annual General Meeting of Shareholders (AGM) to change the Total Shareholder Return vesting scheme for stock options and performance shares (stock incentives).

Shareholders commented at the AGM of 2008 that the TSR vesting scheme allows pay-out ("vesting") of stock incentives for below median performance versus DSM peers. A sharper scheme was suggested. The Supervisory Board reviewed the TSR vesting scheme and submitted a proposal to the upcoming AGM (March 25, 2009) that no longer allows vesting below median performance versus DSM peers, while introducing more upward vesting potential in case of outstanding performance versus peers. In this new proposed TSR vesting scheme the total value of the stock incentives would remain the same as before.

In light of the current public discussion and in particular because DSM wants to take away the perception that the Managing Board of DSM will receive substantially higher compensation for its performance in future, it has been decided to withdraw this proposal from the agenda of the upcoming AGM and as a consequence leave the existing TSR vesting scheme in place for the time being. DSM recognizes that in the context of the current economic circumstances prudence regarding remuneration policies is justified, although the actual total value of the DSM stock incentives plan is at this point already substantially lower than the median of peers in the industry and AEX.

DSM will separately contact its shareholders in the coming period to explain the considerations behind this withdrawal.

DSM strives for high performance in the area of sustainability and aims to maintain a good balance between shareholder value, respect for people and concern for the environment in accordance with the DSM corporate values. DSM will further align its remuneration policy for the Managing Board building upon the corporate values and reflecting the right balance between the interests of DSM's main stakeholders. Changes will also be made in order to comply with the amended Dutch Corporate Governance Code. In the above context DSM will propose a revised remuneration policy for the Managing Board to the AGM in 2010, including a new TSR vesting scheme for stock incentives.

As already announced the 2009 base salaries of the Managing Board will not be increased.

DSM - the Life Sciences and Materials Sciences Company Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: [ www.dsm.com ]

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Copyright © Hugin AS 2009. All rights reserved.